Jaurretche, S.; Conde, H.; Gonzalez Schain, A.; Ruiz, F.; Sgro, M.V.; Venera, G.
Biomarkers for Monitoring Renal Damage Due to Fabry Disease in Patients Treated with Migalastat: A Review for Nephrologists. Genes 2022, 13, 1751.
https://doi.org/10.3390/genes13101751
AMA Style
Jaurretche S, Conde H, Gonzalez Schain A, Ruiz F, Sgro MV, Venera G.
Biomarkers for Monitoring Renal Damage Due to Fabry Disease in Patients Treated with Migalastat: A Review for Nephrologists. Genes. 2022; 13(10):1751.
https://doi.org/10.3390/genes13101751
Chicago/Turabian Style
Jaurretche, Sebastián, Hernan Conde, Ana Gonzalez Schain, Franco Ruiz, Maria Victoria Sgro, and Graciela Venera.
2022. "Biomarkers for Monitoring Renal Damage Due to Fabry Disease in Patients Treated with Migalastat: A Review for Nephrologists" Genes 13, no. 10: 1751.
https://doi.org/10.3390/genes13101751
APA Style
Jaurretche, S., Conde, H., Gonzalez Schain, A., Ruiz, F., Sgro, M. V., & Venera, G.
(2022). Biomarkers for Monitoring Renal Damage Due to Fabry Disease in Patients Treated with Migalastat: A Review for Nephrologists. Genes, 13(10), 1751.
https://doi.org/10.3390/genes13101751